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Stable polymorphs crystallized directly under thermodynamic control in 3D 
nano-confinement: A generic methodology  
Catherine E. Nicholson,† Cen Chen,† Budhika Mendis,‡ and Sharon J. Cooper*,† 
Abstract  
Thermodynamic control of crystallization has been achieved to produce stable polymorphs directly by 
using 3D nano-confinement in microemulsions. The theoretical basis for thermodynamic control of 
crystallization using 3D nano-confinement is outlined. Our approach leap-frogs the usual metastable 
polymorph pathway because crystallization becomes governed by the ability to form stable nuclei, rather 
than critical nuclei. The generality of this approach is demonstrated by crystallizing the stable 
polymorph of three ‘problem’ compounds from microemulsions under conditions yielding metastable 
forms in bulk solution. The polymorphic compounds are mefenamic acid (2-[(2,3-
(dimethylphenyl)amino] benzoic acid), glycine (aminoethanoic acid) and the highly polymorphic 5-
methyl-2-[(2-nitrophenyl) amino]-3-thiophenecarbonitrile, commonly known as ROY because of its red, 
orange and yellow polymorphs. Application of this methodology should prevent another Ritonavir-type 
disaster, whereby a marketed drug transforms into a more stable form, reducing its bioavailability and 
effectiveness.  The lowest energy nuclei selectively grow in our approach. Consequently this also 
provides a generic method for producing higher crystallinity materials, which may prove beneficial for 
crystallizing proteins and inorganic nanocrystals. 
 
Statement of urgency and brief summary of significant findings. We believe the paper fulfills the 
requirements of urgency for a Communication because it details for the first time a generic method to 
obtain thermodynamic control of crystallization. This enables stable polymorphs to be crystallized 
directly, to prevent another Ritonavir-type disaster.  The methodology used selectively grows the lowest 
energy crystal nuclei, so it can also produce materials with higher crystallinity, which may prove of use 
for a wide range of crystalline materials, including potentially proteins. 
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Fax: +44 (0)191 334 2051 
sharon.cooper@durham.ac.uk 
 2 
Stable polymorphs crystallized directly under 
thermodynamic control in 3D nano-confinement: A 
generic methodology  
Catherine E. Nicholson,† Cen Chen,† Budhika Mendis,‡ and Sharon J. Cooper*,† 
†Department of Chemistry, University Science Laboratories, South Road, Durham, DH1 3LE, UK. 
‡Department of Physics, Durham University, South Road, Durham DH1 3LE, UK. 
E-mail: sharon.cooper@durham.ac.uk 
RECEIVED DATE (to be automatically inserted after your manuscript is accepted if required 
according to the journal that you are submitting your paper to) 
Abstract Thermodynamic control of crystallization has been achieved to produce stable polymorphs 
directly by using 3D nano-confinement in microemulsions. The theoretical basis for thermodynamic 
control of crystallization using 3D nano-confinement is outlined. Our approach leap-frogs the usual 
metastable polymorph pathway because crystallization becomes governed by the ability to form stable 
nuclei, rather than critical nuclei. The generality of this approach is demonstrated by crystallizing the 
stable polymorph of three ‘problem’ compounds from microemulsions under conditions yielding 
metastable forms in bulk solution. The polymorphic compounds are mefenamic acid (2-[(2,3-
(dimethylphenyl)amino] benzoic acid), glycine (aminoethanoic acid) and the highly polymorphic 5-
methyl-2-[(2-nitrophenyl) amino]-3-thiophenecarbonitrile, commonly known as ROY because of its red, 
orange and yellow polymorphs. Application of this methodology should prevent another Ritonavir-type 
disaster, whereby a marketed drug transforms into a more stable form, reducing its bioavailability and 
effectiveness.  The lowest energy nuclei selectively grow in our approach. Consequently this also 
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provides a generic method for producing higher crystallinity materials, which may prove beneficial for 
crystallizing proteins and inorganic nanocrystals. 
MANUSCRIPT TEXT  
In 1897 Ostwald coined his now famous rule of stages1 stating that metastable polymorphs crystallize 
initially. The metastable polymorphs may then transform into more stable forms, but the time-scale 
involved is highly variable. Ostwald’s rule of stages is often obeyed because crystallization is typically 
under kinetic, rather than thermodynamic control. Consequently, and despite extensive screening tests, 
pharmaceutical companies cannot guarantee their marketed drug will not transform into a more stable 
polymorph with a lower bioavailability, making the drug less effective. This happened to the infamous 
anti-aids drug Ritonavir in 1998, forcing the removal of the drug from the market and its reformulation,2 
to the cost of several hundred million dollars. In this paper, we show how to ‘leap-frog’ Ostwald’s rule 
of stages by using the 3D nano-confinement of microemulsions to exert thermodynamic control over 
crystallization. Microemulsions3 with 3D nano-confinement comprise thermodynamically stable 
nanoscale droplets of a liquid/solution (the confined phase), dispersed in an immiscible liquid/solution 
(the continuous phase), with surfactant molecules residing at the droplet interface. The droplet size is 
typically 2-10 nm, with a relatively narrow polydispersity of σR/Rmax ≈ 0.1-0.2, where σR is the Gaussian 
distribution standard deviation and Rmax is the modal droplet radius.4 Here we use the term 
‘microemulsion’ to also encompass swollen micelles. Crystallization in microemulsions has been 
studied previously to produce inorganic nanoparticles5,6 and particular polymorphs through specific 
surfactant-polymorph interactions.7-9 This study, however, reveals how generic thermodynamic control 
is achievable, to enable direct crystallization of stable polymorphs. 
 
Crystallization occurs from solutions that are supersaturated, i.e. that have solute concentrations above 
their saturation values, csat,, where csat is the solute concentration in equilibrium with macroscopic 
crystals (Supporting Information (SI) section 2.1). For an ideal solution, the supersaturation is 
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( )ln / satkT c cµ∆ = , where k is the Boltzmann constant, T is temperature and c/csat, the ratio of the solute 
concentration compared to its saturation value, is known as the supersaturation ratio.
 
Crystallization 
involves two stages: nucleation and crystal growth. Nucleation consists of overcoming the 
crystallization energy barrier, ∆F*, arising from creating an interface between the nucleus and solution. 
Crystal nuclei corresponding to this energy maximum are termed critical nuclei. These critical nuclei 
grow until the supersaturation is relieved. The nucleation barrier, ∆F*, for the stable polymorph is 
higher than for a metastable polymorph if Ostwald’s rule of stages is obeyed. An example is shown 
schematically in Fig. 1a for a polymorphic compound with stable polymorph A and metastable 
polymorph B. In such a system, B will tend to crystallize first and the existence of stable polymorph A 
may never be known. However, we can ‘leap-frog’ Ostwald’s rule of stages and crystallize the stable 
polymorph directly by using a 3D nano-confined solution. The scientific rationale is as follows.  
 
For crystallization from 3D nano-confined solutions, a minimum in the free energy arises due to the 
decrease in solute concentration, and hence supersaturation, as the new crystal phase grows.10,11 In 
particular, adopting a classical homogeneous nucleation approach for crystallization from an ideal 
solution in a spherical confining volume, V, the Helmholtz free energy change, ∆F, to produce a nuclei 
containing n molecules would be given by:12 
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, γ and A are the interfacial tension13 and surface area, respectively, 
at the nucleus-solution interface, N is the initial number of solute molecules when n = 0, v is the nucleus 
volume, vc is the molecular volume of the crystalline species and c0 is the initial solute concentration 
when n = 0. The first two terms comprise those expected from classical nucleation theory for 
crystallization from unconfined volumes, whilst the third term provides the correction due to the 
supersaturation depletion as the nucleus grows.  
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Figure 1 Figure caption. Example graphs of free energy change, ∆F vs. nucleus size, r for systems 
crystallizing from (a) bulk solution and (b), (c), (d), a 3D nano-confined solution. Polymorph A (red) is 
stable whilst polymorph B (blue) is metastable. In (a) the bulk solution case, Ostwald’s rule of stages is 
obeyed with polymorph B tending to crystallize first. In (b) crystallization is disfavoured and the system 
is stabilized due to 3D nano-confinement. In (c) thermodynamic control over crystallization is achieved 
as only polymorph A will tend to crystallize, but thermodynamic control will typically be lost for system 
(d), with both polymorphs tending to crystallize. 
 
The free energy change at the minimum is denoted *minF∆ , and the corresponding nucleus size is 
*
minr  
(Fig. 1b). The stable polymorph is the least soluble, so polymorph A can grow to larger sizes than 
a 
b 
c 
d 
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metastable B before its supersaturation is depleted, thus * *min, min,A Br r> . This larger size and the 
polymorph’s greater stability mean we would typically expect * *min, min,A BF F∆ < ∆ . The population of *minr  
nuclei at equilibrium depends upon the Boltzmann factor, ( )*minexp /F kT−∆ , and so will be sizeable for 
*
minF kT∆ ≤ , with (near) stable nuclei produced. Consequently, thermodynamic control is obtained for 3D 
nano-confinements when only the stable polymorph A has *minF kT∆ ≤  (Fig. 1c), as then only this form 
will have a sizeable population of (near) stable nuclei, provided its nucleation energy barrier is 
surmountable. The latter can be ensured by crystallizing from sufficiently small droplets, since these 
require such high initial supersaturations to enable (near) stable nuclei to form. 
 
For microemulsions, there will be a range of droplet sizes and concentrations of solute molecules 
within the droplets. Consequently, thermodynamic control is attainable when droplets with the largest 
supersaturations and sizes contain (near) stable nuclei of the stable polymorph, but negligible quantities 
of the other forms. The key to finding this specific condition is to initially obtain a supersaturated system 
that is stabilized solely due to 3D nano-confinement. Such a system has sufficient supersaturation within 
the 3D nano-confinement to form critical nuclei, but the population of any larger (near) stable nuclei is 
negligible, i.e. *minF∆ >> kT even for droplets with the largest supersaturations and sizes (Fig. 1b). This 
system is characterized by crystallization being severely hindered/prevented compared to the analogous 
unconfined system. Crystallization under thermodynamic control is then induced by increasing the 
supersaturation until (near) stable nuclei of only the stable polymorph form (Fig. 1c). With further 
supersaturation increases, thermodynamic control can be retained provided the reverse process of *minr  
nuclei dissolution is sufficiently rapid that the equilibrium concentration of *minr
 
nuclei can be 
established. This depends upon the magnitude of *F∆ - *minF∆ . If the nucleation barrier *F∆  is 
surmountable but  
*F∆ - *minF∆ >> kT, i.e. *minF∆  < 0 as in Fig 1d, then the dissolution rate of the 
*
minr
 
nuclei will be slow.  
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The relative proportion of the *min,Ar  and 
*
min,Br  will then depend principally upon their rates of formation, 
i.e. the system will come under kinetic control and thermodynamic control will be lost (Fig. 1d). 
 
The (near) stable nuclei within the microemulsion droplets grow to larger dimensions by the following 
process. Collisions occur between the droplets and the most energetic of these cause transient droplet 
dimers to form, with accompanying exchange of interior content.5 This enables the (near) stable nuclei 
to gain access to more molecules and grow until they become larger than the droplets and so are no 
longer confined. Further growth can then occur to produce ~µm or mm-sized crystals either from the 
typically miniscule concentration of their molecules in the continuous phase, or via contact with the 
interior of the microemulsion droplets arising from energetic collisions. Although not observed here, a 
metastable polymorph could potentially have the lowest *minr  and *minF∆  if, e.g. it was sufficiently 
stabilized by the surrounding solvent. This possibility can be readily checked by using a different 
solvent, or by gradually increasing the supersaturation until crystals/nanocrystals of more than one 
polymorph crystallize, so that all low energy polymorphs can be identified. We demonstrate the 
generality of our thermodynamic control for three ‘problem’ polymorphic compounds, mefenamic acid, 
glycine and ROY, which have well-known difficulty in crystallizing their stable polymorphs. 
 
Mefenamic acid has two polymorphs, Form I, which is stable at ambient temperatures, and metastable 
Form II. Crystallization of mefenamic acid from bulk DMF produces only Form II, irrespective of the 
crystallization rate or temperature.14-16 In contrast, Form I nanocrystals were evident from TEM analysis 
on DMF microemulsions cooled from 50 to 8 °C over 12 hours and then left at 8 °C for 12 hours (Fig. 
2a, b). These microemulsions had mean hydrophilic core radii of 1.6 nm and mean initial 
supersaturation ratios, ( )sat initialc c with respect to Form I of 4.1-7.0. Crystallization was only just 
possible for ( )sat initialc c = 4.1. The nanocrystals were predominantly of Form I for ( )sat initialc c  = 4.1-5.3, 
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but thereafter Form II nanocrystals become increasingly evident, with ( )sat initialc c  ≥ 6.1 resulting in 
predominantly Form II. This finding was confirmed by in situ Raman spectroscopy on ~mm-sized 
crystals, with Form I and Form II crystals obtainable from DMF microemulsions and bulk DMF 
solution, respectively (Fig. 2c). Form I has characteristic peaks at 623, 702 and 1581 cm-1 whilst Form II 
has characteristic peaks at 631, 694 and 1573 cm-1. The AOT (sodium dioctyl sulfosuccinate) surfactant 
used in the microemulsions does not induce Form I crystallization (SI section 2.2), so its occurrence is 
not attributable to the surfactant. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 Figure caption. (a) High resolution TEM image from an 8 °C mefenamic acid-in-DMF 
microemulsion of droplet size 1.6 nm with ( )sat initialc c  = 4.7 1 day after cooling to 8 °C showing a ~20 
nm nanocrystal within a mefenamic acid nanocrystal cluster. (b) Fourier transform of the red boxed 
region in (A) showing a “diffraction pattern” consistent with the Form I [1 11] zone axis. (c) in-situ 
Raman spectra from 400-1800 cm-1 showing Form I in red crystallized from a DMF microemulsion with 
a b 
c 
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( )sat initialc c  = 5.3 compared to Form II in blue crystallized from bulk DMF. The inset shows the 600-720 
cm-1 region. 
 
Glycine has three polymorphs, α, β, and γ, which are obtainable under ambient conditions. The γ-form 
is the stable form, but was only discovered in 1954, over 40 years after the α-polymorph.17 It is 
extremely difficult to obtain the γ-form from neutral aqueous solution unless, for example, specific 
additives7,8,18-20 or very low supersaturations21 are employed. This difficulty arises from the small 
stability difference of ≈0.2 kJ mol-1 between the bulk γ- and α-forms at ambient temperatures22,23 and 
because the γ-form grows 500 times slower than the α-form in aqueous solution.23 The microemulsions 
from which glycine was crystallized used the surfactants Span 80 (sorbitan monooleate) and Brij 30 
(polyethylene glycol dodecyl ether), which are known to induce crystallization of metastable forms at 
planar interfaces or in aqueous emulsions.7,24,25 Hence obtaining the stable γ-form from these 
microemulsions was a stringent test of our hypothesis. Nevertheless, we obtained the γ-form as the 
sole/majority product by adding aqueous methanol microemulsions to aqueous glycine microemulsions 
in quantities just sufficient to cause crystallization. Methanol is a poorer solvent for glycine than water, 
and so on mixing the microemulsions, a relatively rapid (i.e. ~ms to s)5 equilibration of the water and 
methanol between droplets occurred to give droplets with a mean hydrophilic core radius of 3.6 nm and 
( )sat initialc c  = 2.0-2.3 with respect to γ-glycine. TEM analysis showed that predominantly γ-nanocrystals 
of size ≈5 nm had grown 48 hrs after mixing the microemulsions (Fig. 3a, b). After 3 weeks, the ~mm-
sized γ-crystals were analysed by ATR-FTIR spectroscopy (Fig. 3c). Characteristic peaks for γ- and α-
crystals occur at 929 and 910 cm-1, respectively. Fig. 3d provides an optical micrograph showing two γ-
crystals grown from the ( )sat initialc c  = 2.3 system. Increasing the glycine concentration above the 
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minimum required for crystallization led to increasing proportions of α-glycine, with little/no γ-form 
observable for ( )sat initialc c  > 2.5. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 Figure caption. (a) A selected area electron diffraction pattern from a cluster of glycine γ-
nanocrystals grown in 2 days from the mixed microemulsion with ( )sat initialc c  = 2.3; the hexagonal 
symmetry from the [001] zone axis of the γ-polymorph is readily seen. The Bragg peaks appear as arcs 
due to slight in-plane misorientation of the γ-nanocrystals. (b) A high resolution image of part of the 
cluster showing small ≈5 nm nanocrystals. (c) ATR-FTIR spectra from 1000-800 cm-1 showing γ-
crystals (red) from the same microemulsion system aged 3 weeks compared to the α-crystals (blue) 
obtained from the mixed microemulsion when ( )sat initialc c  is higher at 2.9. (d) Optical micrograph of γ-
crystals grown from a mixed microemulsion with ( )sat initialc c  = 2.3. 
 
a   b 
c d 
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ROY has 10 known polymorphs. The large number of polymorphs and their relatively small energy 
differences means that polymorphic control for ROY can be difficult26 without specific additives.27,28 
Nevertheless, the stable yellow prism (Y) form was obtained selectively from microemulsions 
containing ROY mass fractions up to 0.15 in toluene on adding the poorer solvent heptane to give 
heptane:toluene volume ratios of 2:1. This corresponded to ( )sat initialc c  up to 24 with respect to the Y 
form, much greater than the ( )sat initialc c  ~10 value at which crystallization is first observable, and 
resulted in Y crystals being visible within a few hours of preparing the microemulsions. The 
microemulsions were stabilized with the surfactant Igepal CA720 (polyoxyethylene (12) isooctylphenyl 
ether), which does not aid Y crystallization (SI section 2.2), and had a mean hydrophobic core radius of 
2.8 nm. In contrast, the corresponding 0.15 mass fraction bulk experiments (SI section 2.2) produce any 
combination of yellow needles (YN), red prisms (R), orange needles (ON) or Y crystals (Fig. 4a). Fig. 
4b compares the ATR-FTIR spectra of the Y polymorph that crystallizes in the microemulsions to the 
metastable forms obtained predominantly in the bulk. Characteristic peaks occur at 2232, 2221 and 2210 
cm-1 for the Y, YN, and R forms, respectively. ROY differs from mefenamic acid and glycine in that 
crystallization of the stable polymorph involves neither a large nucleation barrier nor a slow growth rate. 
Consequently, the stable form is obtained from microemulsions even when supersaturations much larger 
than the minimum required for crystallization are employed. 
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Figure 4 Figure caption. (a) ROY Y, ON and R crystals grown from bulk experiments. (b) ATR-FTIR 
spectrum from 2275-2175 cm-1 of the stable ROY Y form obtained from 2:1 heptane/toluene 
microemulsions with 0.15 mass fraction ROY in toluene (red) compared to the spectrum obtained from 
a corresponding 2:1 heptane/toluene bulk crystallization (blue) showing YN with a minority of R 
crystals. Note that repeats of the bulk experiment could also produce Y and ON crystals. 
 
For the mefenamic acid, glycine and ROY microemulsions that produced stable polymorphs, the mean 
number of solute molecules within each droplet was only ≈2, 5 and 2-5 respectively. However, because 
the (near) stable nuclei only arise in the largest droplets with the largest supersaturations, these nuclei 
will contain many more molecules than these mean values. An estimate for the glycine system, given the 
0.2 kJ mol-1 free energy difference between the γ- and α-polymorphs, suggests thermodynamic 
preference will arise for (near) stable nuclei containing ~20-30 molecules. Each (near) stable nuclei will 
be surrounded by a slightly supersaturated solution containing ~3 glycine molecules, given the lower 
stability of the nuclei compared to its bulk crystal.  Consequently, (near) stable nuclei are only likely to 
arise in droplets containing ~23-33 glycine molecules. If a Poisson distribution of glycine molecules 
amongst the droplets is assumed, then the proportion of droplets comprising such (near) stable nuclei is 
<10-8. 
a 
b 
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The ability of the (near) stable nuclei to determine the polymorphic outcome shows they contain 
sufficient crystal structure to ensure that outcome. This does not mean ‘amorphous’ or less-structured 
nuclei do not form, just that their stability, and hence population, is lower. We would maintain that 
several nucleation pathways are possible, with the dominant pathway(s) determined by the 
crystallization conditions. In particular, the schematic Fig. 1 implies a ‘classical’ nucleation route 
encompassing a single energy barrier, but thermodynamic control via 3D nano-confinement is also 
applicable to non-classical crystallization comprising two-step nucleation29 and pre-critical clusters 
residing in local energy minima,30 since it is the ability to obtain (near) stable nuclei of only the stable 
polymorph, rather than the nucleation pathway, which ensures the thermodynamic control. 
 
Thermodynamic control is achieved through 3D nano-confinement by using the lowest 
supersaturations necessary to induce crystallization. The mefenamic acid and glycine cases show that the 
stable polymorph is produced when it is not achievable from bulk solution whether due to a high 
nucleation barrier and/or slow growth rate. The ability to crystallize stable polymorphs that have high 
nucleation barriers, in particular, is an important advance, since methods such as those using membrane 
crystallization21 and polymeric heteronuclei28 can only crystallize the stable polymorph if its nucleation 
barrier is low. Thus, our approach provides the generic capability of crystallizing stable polymorphs 
directly, necessary to prevent another Ritonavir-type crisis. Crystallization is ubiquitous. Hence this 
generic ability to obtain stable polymorphs and higher crystallinity materials could potentially find uses 
in fie1ds as diverse as proteinology, optoelectronics and pharmaceuticals. 
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Thermodynamic control of crystallization has been achieved to produce stable polymorphs directly by 
using 3D nano-confinement in microemulsions. The theoretical basis for thermodynamic control of 
crystallization using 3D nano-confinement is outlined. The generality of our approach is demonstrated 
by crystallizing the stable polymorph of three ‘problem’ compounds from microemulsions under 
conditions yielding metastable forms in bulk solution. 
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